Linked Data API

Filter

These are the filters currently being used to limit the search results. Click on the remove filter icon to remove the filter.

tabling member › label	Biography information for Lord Wigley
answer › answer text	%3Cp%3EOrkambi does not have a marketing authorisation in the United Kingdom for use in the treatment of children aged under 12 with cystic fibrosis. Where clinically appropriate and subject to the relevant commissioner making funding available%2C Orkambi may be prescribed as an off-label drug. Off-label prescribing is supported in guidance given to prescribers by both the General Medical Council and by the Medicines and Healthcare products Regulatory Agency.%3C%2Fp%3E
min answer › question first answered	2017-07-11T15:01:27.137Z
max date	2017-06-29
max answer › date of answer	2017-07-17

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are shown at the top of the list. Click on remove this sort to remove a sort and or to reverse the current sort order. Click on the remove all sorting icon to remove all the sorting. Note that sorting can significantly slow down the loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined views, but starred properties are always present no matter what the view. You can star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

Items per page

Choose how many items to view on each page. The more items you view, the longer the page will take to load.

Show Search Form

Search Results

registered interest

date

exactly:

or between:
and

answering body

answering dept id

answering dept short name

answering dept sort name

hansard heading

house id

legislature


pref label

question text

tabling member printed

uin

answer

is ministerial correction

date of answer

exactly:

or between:
and

answer text

answering member printed

question first answered

answering member


label

tabling member


label

746109

registered interest

date

28/06/2017

answering body

Department of Health

answering dept id

answering dept short name

Health

answering dept sort name

Health

hansard heading

Lumacaftor/ivacaftor: Children

house id

legislature

25277

pref label	House of Lords

question text

Her Majesty's Government whether they plan to allow the prescription of the drug Orkambi for cystic fibrosis sufferers under the age of 12; and if not, why not.

tabling member printed

Lord Wigley

uin

HL251

answer

is ministerial correction

date of answer

11/07/2017

answer text

<p>Orkambi does not have a marketing authorisation in the United Kingdom for use in the treatment of children aged under 12 with cystic fibrosis. Where clinically appropriate and subject to the relevant commissioner making funding available, Orkambi may be prescribed as an off-label drug. Off-label prescribing is supported in guidance given to prescribers by both the General Medical Council and by the Medicines and Healthcare products Regulatory Agency.</p>

answering member printed

Lord O'Shaughnessy

question first answered

11/07/2017 15:01:27

answering member

4545

label	Biography information for Lord O'Shaughnessy

tabling member

547

label	Biography information for Lord Wigley